Purpose:To evaluate the combined use of carbon dioxide (CO 2 ) and a gadolinium-based blood-pool agent for magnetic resonance angiography (MRA).
Materials and Methods:After an initial intravenous injection of the blood-pool agent Gadomer (Schering AG, Germany), repeated transcatheter CO 2 injections were performed in the aorta and the renal arteries of two fully-anesthetized pigs. Real-time images were acquired using a true fast imaging with steady-state precession (FISP) sequence.Results: During the CO 2 injections, the Gadomer-enhanced blood was totally replaced, resulting in an immediate, temporary, total signal loss in the vessel lumen. Susceptibility artifacts during the injections or catheter manipulations rarely occurred.
Conclusion:Due to T1-shortening, the circulating bloodpool agent prevents flow artifacts during catheter manipulations because the steady-state is reached much earlier. Therefore, this double-contrast MRA method improves catheter conspicuity and might be helpful for guiding and controlling intravascular procedures during interventional MRI. ACCURATE VISUALIZATION of target vessels and continuous confirmation of vessel patency is essential during intravascular interventions.Most non-contrast-enhanced MR angiography (MRA) sequences, such as time-of-flight and phase-contrast angiography, have limitations when used for guidance of vascular interventions due to their acquisition times of longer than one second. Contrast-enhanced angiography techniques are much faster but require repeated injections due to their very short intravascular retention time. Because large quantities of gadolinium-based contrast agents increase the background signal intensity over the course of the procedure, alternatives are needed.One solution is the use of a real-time bright-blood MR steady-state free precession (SSFP) sequence such as true fast imaging with steady-state precession (true FISP) (1). In addition to the excellent vessel conspicuity, true FISP imaging offers exceptionally high signal with a short repetition time, thus making it an ideal imaging method to guide interventional procedures (2). However, in order to assess blood flow distal to an interventional device such as a catheter or stent, the use of a dark blood agent, like gaseous CO 2 , would be advantageous (3,4). In order to prevent distorting artifacts during catheter manipulation during the SSFP sequences, as suggested by other researchers, we injected a bloodpool agent (5). The T1-shortening caused by the circulating blood-pool agent is known to prevent flow artifacts because the steady state is reached much earlier.The aim of our study is to test the feasibility of the combined use of CO 2 and an intravascular blood-pool agent (Gadomer; Schering AG, Berlin, Germany) for MRA and to discuss its potential use in interventional MRI.